Recombinant Hepatitis E Vaccine (Escherichia Coli)

BIOLOGICAL4 trials

Sponsors

Xiamen Innovax Biotech Co., Ltd

Conditions

Hepatitis E

Phase 4

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)

CompletedNCT02417597

Xiamen Innovax Biotech Co., LtdHepatitis E

Start: 2015-04-30End: 2016-05-31Updated: 2016-05-18

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

CompletedNCT02964910

Xiamen Innovax Biotech Co., LtdHepatitis E

Start: 2016-08-31End: 2017-12-31Updated: 2019-07-25

A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)

CompletedNCT03168412

Xiamen Innovax Biotech Co., LtdHepatitis E

Start: 2017-05-25End: 2018-11-28Updated: 2019-02-21

Safety and Immunogenicity Study of Thiomersal-free Hepatitis E Vaccine in People Ages 16 Years and Above

CompletedNCT06564116

Xiamen Innovax Biotech Co., LtdHepatitis E

Start: 2023-03-22End: 2024-03-28Updated: 2024-08-21

Related Papers

Safety and immunogenicity of thiomersal-free recombinant hepatitis E vaccine: A randomized, double-blind, active-controlled study.

2025-07-20

Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial.

2019-01-3116 citations